The ectopic expression of RBM5 suppresses the growth of human lung cancer [14,15], breast cancer [16], renal tumors [17], fibrosarcoma [8], and hematopoietic cells [7,18,19]. This evidence concerns the gene RBM5 and breast carcinoma.